Bret Christensen resigns as CEO of biote; Robert Peterson named interim CEO; Marc Beer appointed Executive Chairman
I'm LongbridgeAI, I can summarize articles.BioTE accepted CEO Bret Christensen's resignation effective June 8, 2026. Robert Peterson was appointed Interim CEO and director, while Marc Beer became Executive Chairman. Christensen will remain a Class III director until 2028 with specific separation terms. Peterson continues as CFO and serves as a Class I director until 2029. The board size increased to eight members.
biote accepted Bret Christensen's resignation as Chief Executive Officer of BioTE effective June 8, 2026, appointed Robert Peterson as Interim Chief Executive Officer and director effective June 8, 2026, and named Marc Beer Executive Chairman effective June 8, 2026.
| Individual | Bret Christensen | Robert Peterson | Marc Beer |
| Role | Chief Executive Officer of BioTE (resigning); will serve as Class III director | Chief Financial Officer & Chief Business Officer of BioTE; appointed Interim Chief Executive Officer and director | Executive Chairman of the Board |
| Type of Change | Resigned from CEO role; continues as Class III director | Appointed Interim Chief Executive Officer; appointed director | Appointed |
| Effective Date | June 8, 2026 | June 8, 2026 | June 8, 2026 |
| Reason | Not due to disagreement with BioTE or the Company on operations, policies or practices | To fill vacancy created by Christensen's resignation | Not disclosed |
| Replacement Info | Replaced by Robert Peterson as Interim CEO of BioTE | Not disclosed | Not disclosed |
| Background Details | Will serve on the Board as Class III director until 2028 Annual Meeting; granted separation terms including 130,000 share option and 3-month post-separation option exercise period | Will become principal executive officer and continue as principal financial officer; compensation terms as Interim CEO not yet determined; will serve as Class I director until 2029 Annual Meeting | Services Agreement provides $521,200 annual base, eligible for up to 85% annual bonus, granted option for 114,157 shares; certain change-in-control and termination benefits described |
| Board/Committee Role Changes | Will serve as Class III director until 2028 Annual Meeting | Board size increased to eight directors; will serve as Class I director until 2029 Annual Meeting | Appointed Executive Chairman; no committee changes disclosed |
Original SEC Filing: biote Corp. [ BTMD ] - 8-K - Jun. 02, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.